Search This Blog

Friday, July 24, 2026

MacroGenics Phase 1 in head and neck cancer meets Stage 1 response threshold, moves to Stage 2

 

MacroGenics Phase 1 MGC026 trial in head and neck cancer meets Stage 1 response threshold, advances to Stage 2

  • Interim data from the MGC026 Phase 1 trial will be presented at ESMO 2026.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)